# BIXT (Bioxytran, Inc.) - SEC EDGAR Financial Statements

> Bioxytran, Inc. reported $245K in total assets and a net loss of $4.49M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/BIXT
- Markdown: https://convexityos.com/fundamentals/BIXT.md
- SEC CIK: 0001445815
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:11 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001445815&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$3.40M | Operating profit |
| Net Income | FY 2025 | -$4.49M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.04 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $74K | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | -- | -- | -- | -- | $191K | $246K |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | -- | -- | $104K | $96K |
| **Gross Profit** | -- | -- | -- | -- | -- | -- | -- | -- | $87K | $150K |
| Research & Development | $454K | $112K | $1.15M | $978K | $2.01M | $545K | -- | -- | -- | -- |
| Selling, General & Admin | -- | -- | -- | -- | -- | -- | -- | -- | $398K | $821K |
| Total Operating Expenses | $1.84M | $2.22M | $3.80M | $2.13M | $4.21M | $1.27M | $1.63M | $215K | $398K | $821K |
| **Operating Income** | -$1.84M | -$2.22M | -$3.80M | -$2.13M | -$4.21M | -$1.27M | -$1.63M | -$215K | -$311K | -$671K |
| **EBITDA** | -- | -- | -- | -- | -- | -- | -- | -- | -$293K | -$644K |
| Interest Expense | $134K | $84K | $193K | -- | $2.02M | $1.01M | $42K | $3.7K | $7.8K | $7.8K |
| Income Before Tax | -$2.12M | -$2.38M | -$4.56M | -$2.66M | -$4.53M | -$2.54M | -$1.86M | -$296K | -- | -$697K |
| Income Tax Expense | -- | -- | -- | -- | -- | -- | -- | $400 | -- | -- |
| **Net Income** | -$2.12M | -$2.37M | -$4.47M | -$2.46M | -$4.03M | -$2.54M | -$1.86M | -$296K | -$318K | -$697K |
| Basic EPS | -$0.02 | -$0.02 | -$0.03 | -$0.02 | -$0.04 | -$0.03 | -$0.02 | $0.00 | -$0.01 | -$0.03 |
| **Diluted EPS** | -$0.02 | -$0.02 | -$0.03 | -$0.02 | -$0.04 | -$0.03 | -$0.02 | $0.00 | -$0.01 | -$0.03 |
| Basic Shares Outstanding | 91.8M | 138.6M | 134.0M | 115.1M | 106.3M | 94.0M | 85.6M | 85.1M | 39.5M | 26.5M |
| Diluted Shares Outstanding | 91.8M | 138.6M | 134.0M | 115.1M | 106.3M | 94.0M | 85.6M | 85.1M | 39.5M | 26.5M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | -- | $255K | $225K | $2.0K | $0 | $102K | $350K | $34K |
| Total Operating Expenses | $203K | $655K | $1.93M | $607K | $496K | $224K | $515K | $488K |
| **Operating Income** | -$203K | -$655K | -$1.93M | -$607K | -$496K | -$224K | -$515K | -$488K |
| Interest Expense | $37K | $36K | $36K | $37K | $37K | $30K | $31K | $20K |
| Income Before Tax | -$1.28M | -$620K | -$2.07M | -$522K | -$283K | $35K | -$1.35M | -$752K |
| **Net Income** | -$1.28M | -$620K | -$2.07M | -$522K | -$283K | $35K | -$1.35M | -$752K |
| Basic EPS | $0.00 | -$0.01 | -$0.02 | -- | $0.00 | $0.00 | -$0.02 | -- |
| **Diluted EPS** | $0.00 | -$0.01 | -$0.02 | -- | $0.00 | $0.00 | -$0.02 | -- |
| Basic Shares Outstanding | 114.7M | 114.4M | 112.3M | -- | 89.0M | 88.8M | 88.8M | -- |
| Diluted Shares Outstanding | 114.7M | 114.4M | 112.3M | -- | 89.0M | 88.8M | 88.8M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $510K | $5.2K | $26K | $295K | $72K | $42K | $170K | $36K | $110 | $11K |
| **Cash & Short-Term Investments** | $510K | $5.2K | $26K | $295K | $72K | $42K | $170K | $36K | $110 | $11K |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | $50K | -- | $23K | $9.6K |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- | $5.3K | $6.3K |
| **Total Current Assets** | $513K | $5.2K | $26K | $295K | $72K | $316K | $220K | $36K | $110 | $27K |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | -- | -- | -- | -- | $682K | $25K |
| Intangible Assets | $145K | $134K | $113K | $76K | $47K | $10K | -- | -- | -- | -- |
| **Total Non-Current Assets** | $145K | $134K | $112K | $76K | $47K | $10K | $0 | $0 | $0 | $25K |
| **Total Assets** | $659K | $139K | $139K | $371K | $119K | $326K | $220K | $36K | $110 | $52K |
| Accounts Payable | -- | -- | -- | $710K | -- | -- | -- | -- | -- | -- |
| Short-Term Debt | -- | $48K | -- | -- | -- | -- | -- | -- | $25K | -- |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | -- | -- | $4.8K | -- |
| Other Current Liabilities | -- | -- | -- | $710K | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $3.25M | $1.93M | $3.24M | $3.66M | $3.28M | $2.27M | $1.02M | $262K | $1.4K | $342K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $3.25M | $1.93M | $3.24M | $3.66M | $3.28M | $2.27M | $1.02M | $262K | $1.4K | $342K |
| **Total Debt (incl. Leases)** | -- | $48K | -- | -- | -- | -- | -- | -- | $25K | -- |
| Common Stock | $108K | $87K | $145K | $123K | $111K | $97K | $86K | $85K | $85K | $28K |
| Retained Earnings | -$21.04M | -$18.92M | -$15.70M | -$11.22M | -$8.75M | -$4.72M | -$2.24M | -$383K | -$86K | -$13.88M |
| **Total Stockholders' Equity** | -$2.59M | -$1.79M | -- | -- | -$3.16M | -$1.94M | -$799K | -$225K | -$1.3K | -$291K |
| Total Equity | -$2.59M | -$1.79M | -$3.10M | -$3.30M | -$3.16M | -$1.94M | -$799K | -$225K | -$1.3K | -$291K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $74K | $177K | $463K | $510K | $14K | $3.1K | $4.3K | $5.2K |
| **Cash & Short-Term Investments** | $74K | $177K | $463K | $510K | $14K | $3.1K | $4.3K | $5.2K |
| **Total Current Assets** | $74K | $177K | $463K | $513K | $14K | $3.1K | $4.3K | $5.2K |
| Intangible Assets | $170K | $156K | $152K | $145K | $142K | $144K | $132K | $134K |
| **Total Non-Current Assets** | $170K | $156K | $152K | $145K | $142K | $144K | $132K | $134K |
| **Total Assets** | $245K | $333K | $615K | $659K | $156K | $148K | $136K | $139K |
| Short-Term Debt | -- | -- | -- | -- | -- | $48K | $48K | $48K |
| **Total Current Liabilities** | $6.46M | $5.27M | $5.01M | $3.25M | $3.06M | $2.78M | $2.84M | $1.93M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $6.46M | $5.27M | $5.01M | $3.25M | $3.06M | $2.78M | $2.84M | $1.93M |
| **Total Debt (incl. Leases)** | -- | -- | -- | -- | -- | $48K | $48K | $48K |
| Common Stock | $115K | $115K | $113K | $108K | $89K | $89K | $89K | $87K |
| Retained Earnings | -$25.01M | -$23.73M | -$23.11M | -$21.04M | -$20.52M | -$20.24M | -$20.27M | -$18.92M |
| **Total Stockholders' Equity** | -$6.21M | -$4.94M | -$4.39M | -$2.59M | -$2.90M | -$2.64M | -$2.71M | -$1.79M |
| Total Equity | -$6.21M | -$4.94M | -$4.39M | -$2.59M | -$2.90M | -$2.64M | -$2.71M | -$1.79M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.12M | -$2.38M | -$4.56M | -$2.66M | -$4.53M | -$2.48M | -$1.86M | -$296K | -$318K | -$697K |
| Depreciation & Amortization | -- | -- | -- | -- | -- | -- | -- | -- | $18K | $28K |
| Stock-Based Compensation | $197K | $634K | $198K | $178K | $583K | $248K | $1.12M | -- | -- | -- |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -- | -- | -$13K | -$9.6K |
| Change in Inventory | -- | -- | -- | -- | -- | -- | -- | -- | $1.0K | -$6.3K |
| **Operating Cash Flow** | -$526K | -$381K | -$775K | -$1.81M | -$1.70M | -$1.10M | -$431K | -$186K | -$19K | -$42K |
| **Investing Cash Flow** | -$23K | -$28K | -$44K | -$32K | -$37K | -$10K | -- | -- | -- | -- |
| Common Stock Issued | $439K | $63K | $550K | -- | $600K | $600K | $20K | -- | -- | $50K |
| **Financing Cash Flow** | $1.05M | $389K | $550K | $2.06M | $1.76M | $981K | $564K | $222K | $23K | $50K |
| **Net Change in Cash** | $505K | -$21K | -$269K | $223K | $31K | -$128K | $133K | $36K | $4.2K | $7.6K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.28M | -$620K | -$2.07M | -$522K | -$283K | $35K | -$1.35M | -$752K |
| Stock-Based Compensation | $11K | $7.8K | $1.29M | $85K | $44K | $42K | $27K | $229K |
| **Operating Cash Flow** | -$92K | -$350K | -$239K | -$237K | -$49K | -$73K | -$167K | -$128K |
| **Investing Cash Flow** | -$19K | -$9.4K | -$9.2K | -$6.2K | -$4.2K | -$13K | -$15 | -$12K |
| Common Stock Issued | $0 | $45K | $146K | -- | -- | -- | -- | $0 |
| **Financing Cash Flow** | $7.9K | $73K | $201K | $739K | $65K | $85K | $167K | $110K |
| **Net Change in Cash** | -$103K | -$286K | -$47K | $495K | $11K | -$1.2K | -$806 | -$30K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -- | -- | -- | -- | 45.6% | 60.9% |
| **Operating Margin** | -- | -- | -- | -- | -- | -- | -- | -- | -162.5% | -272.3% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -- | -- | -- | -166.6% | -282.7% |
| Return on Assets (ROA) | -322.4% | -1706.4% | -3208.8% | -664.2% | -3379.8% | -779.0% | -846.2% | -814.1% | -289442.7% | -1348.4% |
| Current Ratio | 0.16x | 0.00x | 0.01x | 0.08x | 0.02x | 0.14x | 0.22x | 0.14x | 0.08x | 0.08x |
| Quick Ratio | 0.16x | 0.00x | 0.01x | 0.08x | 0.02x | 0.02x | 0.22x | 0.14x | -3.63x | 0.06x |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -- | -- | -- | -22.5% | -3.6% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -42.0% | +25.0% |
| 5Y Revenue / Share Growth | -- | -- | -- | -- | -- | -- | -- | -- | +104.0% | +758.1% |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -1833.9% | -1048.0% | -461.3% | -322.4% | -1505.5% | -1669.6% | -2322.5% | -1706.4% |
| Current Ratio | 0.01x | 0.03x | 0.09x | 0.16x | 0.00x | 0.00x | 0.00x | 0.00x |
| Quick Ratio | 0.01x | 0.03x | 0.09x | 0.16x | 0.00x | 0.00x | 0.00x | 0.00x |
| **Net Income Growth (YoY)** | -- | -1849.3% | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
